Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Find out the key elements that should be included in any financial plan. Make sure your financial strategy is comprehensive and effective.
26,586 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Compass, Rocket, and Redfin announce a new syndication to display compass coming soon listings on Redfin's platform, ...
Two AI stocks carry consensus upside targets of 47% and 54%. This guide explains what drives those bets and how to ev...
A major investment manager disclosed a sizable share disposal in a U.S. utility stock through an SEC filing. The move...
Rocket Lab delivers a record quarter that lights up the stock market today. This deep dive explains the rally, the ba...
DLocal faces a pivotal year as Q1 2026 results shape the path to 2026 earnings. This guide breaks down the key metric...
China is reshaping higher education by cutting arts degrees to prioritize AI-ready programs. Industry leaders urge fa...
New data in 2026 cast doubt on the notion that ditching college ‘more secure’ automatically leads to a stable career,...
Tilray is expanding beyond its home market, but the stock market isn’t fully pricing in that growth. This article bre...
ServiceNow has built a durable software platform with strong margins and steady growth. This article explains why the...
A new Morgan Stanley note argues Rocket Lab’s shift into satellite data and services could unlock substantial upside,...
SpaceX stock appears to be trading well below its IPO price, but price alone doesn’t determine value. Here’s a practi...